ASX · Stocky rates: Hold

NINE ENT FPO [NEC] (NEC.AX)

A$0.97 ▲ +0.00% as of 24 Aug, 13:02

Stocky turns companies like NINE ENT FPO [NEC] into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.

Try Stocky free →
62
/ 100
Hold

What Stocky thinks

Hold. NEC.AX trades at a reasonable 9.8× forward earnings with a solid Value Compounder Score of 70, reflecting stable cash generation and financial resilience. However, Growth Compounder is weak at 40—revenue expansion is modest—and Leadership Alignment at 62.5 suggests alignment exists but lacks the founder-CEO conviction or capital discipline of top-tier compounders. Fair value, not a margin of safety.

Compounder Score
70/100
Business quality — profitability, growth, capital efficiency.
Leadership Alignment
63/100
Founder-led, insider ownership, capital allocation history.
Vulnerability
50/100
Downside resilience — customer concentration, supply chain, refinancing risk.
Value Score
70/100
Valuation vs peers and history — is this a good price to pay?

What Stocky gives investors that other tools don't

Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for NINE ENT FPO [NEC]:

62
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 62/100, you know instantly whether to dig deeper or skip.

Rated
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

63
LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

50
RISK

Vulnerability Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

NINE ENT FPO [NEC] (NEC.AX) — frequently asked

Is NINE ENT FPO [NEC] (NEC.AX) a good investment right now?

Stocky rates NINE ENT FPO [NEC] (NEC.AX) at 62/100 — a Hold — quality is solid but valuation or risk factors cap upside. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Hold. NEC.AX trades at a reasonable 9.8× forward earnings with a solid Value Compounder Score of 70, reflecting stable cash generation and financial resilience. However, Growth Compounder is weak at 40—revenue expansion is modest—and Leader

What is NEC.AX's Stocky Verdict?

NEC.AX's current Stocky Verdict is 62/100, placing it in the "Hold" band. This composite combines a 70/100 Compounder score, 63/100 Leadership, Moat rating, and analyst signal.

Does NINE ENT FPO [NEC] have a competitive moat?

Stocky hasn't finalised a Moat Score for NINE ENT FPO [NEC] yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.

Is NINE ENT FPO [NEC]'s leadership aligned with shareholders?

NINE ENT FPO [NEC] scores 63/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.

What are the biggest risks to NEC.AX?

NINE ENT FPO [NEC]'s Vulnerability Profile scores 50/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to NINE ENT FPO [NEC].

This is just the surface. See the whole picture on NINE ENT FPO [NEC].

Sign up free and unlock the full analysis on NEC.AX — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering NEC.AX — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Vulnerability Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for NEC.AX.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how NEC.AX changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to NEC.AX?" · "Is NEC.AX overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

STOCKY VERDICT
62
/ 100 · Hold

See NINE ENT FPO [NEC] the Stocky way

This page is just a preview. Open the live, interactive version for the full picture:

Stocky Verdict
A plain-English Buy / Hold / Sell score out of 100.
Compounder & Value scores
How strong the business is — and whether it looks cheap.
Interactive charts
1M to 5Y price history with company events plotted on it.
Top analyst targets
What the best-rated Wall Street analysts expect next.
What if? simulator
See what an investment in NEC.AX would be worth today.
Practice portfolio
Buy NEC.AX with virtual money and track it — zero risk.
Free · no real money · learn by doing Open NEC.AX in Stocky →

Or jump straight to the interactive dashboard for NEC.AX in the app.